FDA grants accelerated approval to tarlatamab-dlle for extensive stage small cell lung cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-tarlatamab-dlle-extensive-stage-small-cell-lung-cancer